Bausch & Lomb   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Rochester NY United States (1853)
Status: Acquired by Bausch Health Companies (2013)

Organization Overview

First Clinical Trial
1990
NCT00000145
First Marketed Drug
1981
naphazoline (visine)
First NDA Approval
1989
metipranolol (optipranolol)
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

BAUSCH AND LOMB | BAUSCH AND LOMB INC | Bausch & Lomb Incorporated | Baush and Lomb